The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Abstract. Antibody–drug conjugates (ADC) represent one of the most rapidly expanding treatment modalities in oncology, with 11 ADCs approved by the FDA and more than 210 currently being tested in clin...
